中文 | English
Return
Total: 58 , 1/6
Show Home Prev Next End page: GO
Author:(Shiliang JIANG)

1.Association of physical activity level and all-cause mortality among stroke survivors: evidence from NHANES 2007-2018.

Fude LIU ; Xiangning HAN ; Yawen CHENG ; Ning ZHU ; Shiliang JIANG ; Jiahao LI ; Jin ZHAO ; Guogang LUO

Environmental Health and Preventive Medicine 2025;30():27-27

2.Pharmacodynamic study of Tianjiang xueshuantong pills in the treatment of coronary heart disease

Wenjie LI ; Yingying LI ; Jiang BIAN ; Ting LIU ; Yunxuan GUAN ; Xibiao ZHANG ; Shiliang ZHOU ; Li SUN ; Xi JIANG

China Pharmacy 2025;36(11):1358-1363

3.Acute phase neurovascular coupling function in patients with minor ischemic stroke or transient ischemic attack due to intracranial large artery moderate-to-severe stenosis or occlusion and its correlation with quality of life

Gezhi YAN ; Meiling SHANG ; Lu QUAN ; Ling MA ; Xiaotong CHI ; Bingbing GUO ; Zepeng TIAN ; Shiliang JIANG ; Fude LIU ; Jianfeng HAN ; Wanghuan DUN ; Jia YU

Chinese Journal of Cerebrovascular Diseases 2025;22(11):744-754,776

4.Acute phase neurovascular coupling function in patients with minor ischemic stroke or transient ischemic attack due to intracranial large artery moderate-to-severe stenosis or occlusion and its correlation with quality of life

Gezhi YAN ; Meiling SHANG ; Lu QUAN ; Ling MA ; Xiaotong CHI ; Bingbing GUO ; Zepeng TIAN ; Shiliang JIANG ; Fude LIU ; Jianfeng HAN ; Wanghuan DUN ; Jia YU

Chinese Journal of Cerebrovascular Diseases 2025;22(11):744-754,776

5. Exploring the mechanism of elemene synergistic bortezomib against multiple myeloma by ROS-NF-κB-p38MAPK pathway

Ruifang ZHU ; Dongkai GUO ; Hui ZHI ; Yiguo JIANG ; Yueling ZHANG ; Xiaoping QIAN ; Shiliang JI

Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(11):1219-1226

6.Effects of irbesartan combined with 5-fluorouracil on the proliferation and ERK/PPARγ signaling pathway of Lewis lung cancer cells

Meijuan ZHAI ; Shiliang JI ; Yiguo JIANG ; Xiuhua BAI

China Pharmacy 2022;33(16):1986-1989

9.Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.

Rui XIONG ; Leike ZHANG ; Shiliang LI ; Yuan SUN ; Minyi DING ; Yong WANG ; Yongliang ZHAO ; Yan WU ; Weijuan SHANG ; Xiaming JIANG ; Jiwei SHAN ; Zihao SHEN ; Yi TONG ; Liuxin XU ; Yu CHEN ; Yingle LIU ; Gang ZOU ; Dimitri LAVILLETE ; Zhenjiang ZHAO ; Rui WANG ; Lili ZHU ; Gengfu XIAO ; Ke LAN ; Honglin LI ; Ke XU

Protein & Cell 2020;11(10):723-739

10.The Imaging and Clinical Feature Analysis for Behcet's Disease With Coronary Artery Involvement in 6 Patients

Aihua ZHI ; Ruping DAI ; Shiliang JIANG ; Bin LV

Chinese Circulation Journal 2017;32(5):493-496

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 58 , 1/6 Show Home Prev Next End page: GO